This 1 Number Could Mean Billions for Moderna Over the Long Term
27/2 12:15
There were plenty of important numbers in Moderna's (NASDAQ: MRNA) most recent earnings report. And many of them had to do with the billions of dollars the company's coronavirus vaccine is generating. For example, the company reported $18.5 billion in 2021 revenue and $12.2 billi...